Home  Clinical trials Seloken ZOK/Toprol-XL™ (metoprolol CR/XL) Ongoing Studies
|
|
| Seloken ZOK/Toprol-XL™ (metoprolol CR/XL) Ongoing studies |
| Study Number | Study Phase | Start Date | Study Status | | 276 | Phase III | Aug-2001 | Completed | | Reversal of Ventricular Remodeling with Toprol-XL | | D4020C00001 | Phase III | 1-July-2002 | Completed | | A Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® (metoprolol succinate) Extended-release Tablets (metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Open-Label Extension of Protocol 307A. | | D4020C00033 | Phase III | 30-May-2002 | Completed | | Dose Ranging, Safety and Tolerability of TOPROL-XL® (metoprolol succinate) Extended-release Tablets (metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Study. | | D4026C00001 | Phase III | 20-Jun-2003 | Completed | | A phase III, Multi-center, randomized, Double-blind, placebo-controlled, parallel-group factorial study of Metaprolol Succinate extended release tablets (TOPROL-XL) Hydrochlorothiazide and their combination in patients with essential hypertension. |
|
|
|